A National Cancer Database analysis revealed racial and ethnic disparities in patients with gastric cancer in the use of preoperative chemotherapy and in outcomes. READ MORE
The US Food and Drug Administration expanded the approval of a targeted therapy to treat gastric or gastroesophageal junction cancer.
With appropriate selection and on-table gastroscopy when needed, laparoscopic nonanatomic wedge resection can deal with most gastric gastrointestinal stromal tumors.
Everolimus significantly improves progression-free survival in patients with advanced, nonfunctional neuroendocrine tumors of the lung or gastrointestinal tract.